Published in

Royal Society of Chemistry, RSC Medicinal Chemistry, 6(13), p. 737-745, 2022

DOI: 10.1039/d2md00053a

Links

Tools

Export citation

Search in Google Scholar

Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Mitogen-activated protein kinases (MAPKs) govern various cellular programs and crucial intermediate pathways in signaling.